Novozymes and Arla Foods Ingredients have agreed a partnership to develop advanced protein ingredients using precision fermentation. The initial focus of the collaboration will be a solution for disease-specific medical nutrition.
Biotechnology company Novozymes is a world-leader in precision fermentation, a technique that fine-tunes the molecular output of microorganisms, offering greater control over the fermentation process and enabling tailor-made protein compositions. Specialising in the production of enzymes through precision fermentation, it has focused on the exploration of new protein solutions for health and nutrition since 2019. In the co-funded partnership with Arla Foods Ingredients, it will contribute its expertise in the creation of microbial strains for the industrial-scale production of proteins by precision fermentation.
This will be combined with Arla Foods Ingredients’ food technology knowhow – in particular in relation to separation and drying processes – and its knowledge of the regulatory landscape. The initial focus of the collaboration will be a solution for disease-specific medical nutrition – a category in which protein is an essential component – with expansion into other segments anticipated in future.
